Single-dose packets each containing 3 g sodium phenylbutyrate and 1 g taurursodiol.

The recommended initial dosage of RELYVRIO for oral suspension is 1 packet (3 g sodium phenylbutyrate and 1 g taurursodiol) daily for the first 3 weeks. After 3 weeks, increase to the maintenance dosage of 1 packet twice daily

RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.